Contact Dermatitis to Ophthalmic Solutions: An Update
Dermatitis® · 2023
DOI: 10.1089/derm.2023.0033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Dermatitis®, 2023. Verfasst von Sally J Ashton und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Singleton Hospital, Swansea, United Kingdom. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Eyelid and periorbital dermatitis remains a distressing and recalcitrant disease. Contact dermatitis remains the most common cause of eyelid and periorbital dermatitis. Ophthalmic solutions used in the treatment of ophthalmic conditions can often be the cause. This article is an update of our previous study, summarizing the contact allergens involved and the new test concentrations reported to investigate through patch testing. New insights found during the review are also documented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Singleton Hospital, Swansea, United Kingdom.
- Department of Dermatology, Neath and Port Talbot Hospital, Port Talbot, United Kingdom.
ORCID-Profile: Sally J Ashton
Zitieren
APA
Ashton, S. J., & Mughal, A. A. (2023). Contact Dermatitis to Ophthalmic Solutions: An Update. Dermatitis®. https://doi.org/10.1089/derm.2023.0033
Vancouver
Ashton SJ, Mughal AA. Contact Dermatitis to Ophthalmic Solutions: An Update. Dermatitis®. 2023. doi:10.1089/derm.2023.0033
BibTeX
@article{Ashton2023,
author = {Ashton, Sally J and Mughal, Avad A},
title = {Contact Dermatitis to Ophthalmic Solutions: An Update},
journal = {Dermatitis®},
year = {2023},
doi = {10.1089/derm.2023.0033}
}
EUVIMED